NTAGI approves Covovax vaccine for 12 to 17 age group

New Delhi, Apr 29: The Standing Technical Sub-Committee of the NTAGI has recommended the inclusion of the Serum Institute’s Covid jab Covovax in the national anti-coronavirus vaccination programme for children aged 12 to 17 years, sources said on Friday. The

Source: India News, India Breaking News, Latest news headlines in India – Oneindia News